Copyright
©The Author(s) 2023.
World J Gastrointest Endosc. May 16, 2023; 15(5): 376-385
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.376
Published online May 16, 2023. doi: 10.4253/wjge.v15.i5.376
Group | CD4+ | CD8+ | NK cell | ||||||
T0 | T1 | T2 | T0 | T1 | T2 | T0 | T1 | T2 | |
Treatment | 40.65 ± 6.73 | 37.16 ± 5.78a,b | 33.75 ± 5.36a,c | 25.91 ± 6.25 | 22.35 ± 5.49a,b | 21.03 ± 4.35a,c | 14.54 ± 1.34 | 16.61 ± 1.80a,b | 20.74 ± 1.77a,c |
Control | 41.56 ± 7.19 | 35.19 ± 6.31a | 29.09 ± 5.63a | 26.15 ± 5.58 | 21.11 ± 4.74a | 18.49 ± 4.56a | 14.40 ± 1.34 | 21.79 ± 1.45a | 26.81 ± 1.39a |
- Citation: Mi SC, Wu LY, Xu ZJ, Zheng LY, Luo JW. Effect of modified ShengYangYiwei decoction on painless gastroscopy and gastrointestinal and immune function in gastric cancer patients. World J Gastrointest Endosc 2023; 15(5): 376-385
- URL: https://www.wjgnet.com/1948-5190/full/v15/i5/376.htm
- DOI: https://dx.doi.org/10.4253/wjge.v15.i5.376